{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:58:03Z","timestamp":1783940283759,"version":"3.55.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Treatment outcomes in retinopathy of prematurity (ROP) are closely correlated with the location (i.e. zone) of disease, with more posterior zones having poorer outcomes. The most posterior zone, Zone I, is defined as a circle centered on the optic nerve with radius twice the distance from nerve to fovea, or subtending an angle of 30 degrees. Because the eye enlarges and undergoes refractive changes during the period of ROP screening, the absolute area of Zone I according to these definitions may likewise change. It is possible that these differences may confound accurate assessment of risk in patients with ROP. In this study, we estimated the area of Zone I in relation to different ocular parameters to determine how variability in the size and refractive power of the eye may affect zoning. Using Gaussian optics, a model was constructed to calculate the absolute area of Zone I as a function of corneal power, anterior chamber depth, lens power, lens thickness, and axial length (AL), with Zone I defined as a circle with radius set by a 30-degree visual angle. Our model predicted Zone I area to be most sensitive to changes in AL; for example, an increase of AL from 14.20 to 16.58\u00a0mm at postmenstrual age 32\u00a0weeks was calculated to expand the area of Zone I by up to 72%. These findings motivate several hypotheses which upon future testing may help optimize treatment decisions for ROP.<\/jats:p>","DOI":"10.1038\/s41598-022-08680-5","type":"journal-article","created":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T14:21:21Z","timestamp":1647613281000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Modeling absolute zone size in retinopathy of prematurity in relation to axial length"],"prefix":"10.1038","volume":"12","author":[{"given":"Sean K.","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Korot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moosa","family":"Zaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco H.","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Al-Moujahed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia F.","family":"Callaway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Kumm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darius M.","family":"Moshfeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,18]]},"reference":[{"key":"8680_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1542\/peds.2004-1413","volume":"116","author":"WV Good","year":"2005","unstructured":"Good, W. V. et al. The incidence and course of retinopathy of prematurity: Findings from the early treatment for retinopathy of prematurity study. Pediatrics 116, 15\u201323 (2005).","journal-title":"Pediatrics"},{"key":"8680_CR2","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.ajo.2006.05.048","volume":"142","author":"N Azuma","year":"2006","unstructured":"Azuma, N. et al. Early vitreous surgery for aggressive posterior retinopathy of prematurity. Am. J. Ophthalmol. 142, 636\u2013643 (2006).","journal-title":"Am. J. Ophthalmol."},{"key":"8680_CR3","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S0161-6420(93)31664-7","volume":"100","author":"DG Hunter","year":"1993","unstructured":"Hunter, D. G. & Repka, M. X. Diode laser photocoagulation for threshold retinopathy of prematurity. A randomized study. Ophthalmology 100, 238\u2013244 (1993).","journal-title":"Ophthalmology"},{"key":"8680_CR4","doi-asserted-by":"crossref","unstructured":"Early Treatment for Retinopathy of Prematurity Cooperative Group et al. Final visual acuity results in the early treatment for retinopathy of prematurity study. Arch. Ophthalmol. 128, 663\u201371 (2010).","DOI":"10.1001\/archophthalmol.2010.72"},{"key":"8680_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S1091-8531(99)70091-1","volume":"3","author":"PG Steinkuller","year":"1999","unstructured":"Steinkuller, P. G. et al. Childhood blindness. J. AAPOS 3, 26\u201332 (1999).","journal-title":"J. AAPOS"},{"key":"8680_CR6","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jaapos.2012.09.004","volume":"16","author":"L Kong","year":"2012","unstructured":"Kong, L., Fry, M., Al-Samarraie, M., Gilbert, C. & Steinkuller, P. G. An update on progress and the changing epidemiology of causes of childhood blindness worldwide. J. AAPOS 16, 501\u2013507 (2012).","journal-title":"J. AAPOS"},{"key":"8680_CR7","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1001\/archopht.1984.01040030908011","volume":"102","author":"An international classification of retinopathy of prematurity","year":"1984","unstructured":"An international classification of retinopathy of prematurity. The committee for the classification of retinopathy of prematurity. Arch. Ophthalmol. 102, 1130\u20131134 (1984).","journal-title":"Arch. Ophthalmol."},{"key":"8680_CR8","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/j.1395-3907.2003.00171.x","volume":"81","author":"M O\u2019Keefe","year":"2003","unstructured":"O\u2019Keefe, M., Lanigan, B. & Long, V. W. Outcome of zone 1 retinopathy of prematurity. Acta Ophthalmol. Scand. 81, 614\u2013616 (2003).","journal-title":"Acta Ophthalmol. Scand."},{"key":"8680_CR9","doi-asserted-by":"crossref","unstructured":"Multicenter trial of cryotherapy for retinopathy of prematurity. Three-month outcome. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch. Ophthalmol. 108, 195\u2013204 (1990).","DOI":"10.1001\/archopht.1990.01070040047029"},{"key":"8680_CR10","doi-asserted-by":"crossref","unstructured":"Fierson, W. M., American Academy of Pediatrics Section on Ophthalmology, American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus & American Association of Certified Orthoptists. Screening examination of premature infants for retinopathy of prematurity. Pediatrics 131, 189\u201395 (2013).","DOI":"10.1542\/peds.2012-2996"},{"key":"8680_CR11","doi-asserted-by":"crossref","unstructured":"Fierson, W. M., American Academy of Pediatrics Section on Ophthalmology, American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus & American Association of Certified Orthoptists. Screening Examination of Premature Infants for Retinopathy of Prematurity. Pediatrics 142, (2018).","DOI":"10.1542\/peds.2018-3061"},{"key":"8680_CR12","doi-asserted-by":"crossref","unstructured":"International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch. Ophthalmol. 123, 991\u20139 (2005).","DOI":"10.1001\/archopht.123.7.991"},{"key":"8680_CR13","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/j.ophtha.2021.05.031","volume":"128","author":"MF Chiang","year":"2021","unstructured":"Chiang, M. F. et al. International classification of retinopathy of prematurity, Third Edition. Ophthalmology 128, e51\u2013e68 (2021).","journal-title":"Ophthalmology"},{"key":"8680_CR14","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1001\/archopht.1985.01050060045020","volume":"103","author":"RA Gordon","year":"1985","unstructured":"Gordon, R. A. & Donzis, P. B. Refractive development of the human eye. Arch. Ophthalmol. 103, 785\u2013789 (1985).","journal-title":"Arch. Ophthalmol."},{"key":"8680_CR15","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/S0161-6420(92)31812-3","volume":"99","author":"SM Tucker","year":"1992","unstructured":"Tucker, S. M., Enzenauer, R. W., Levin, A. V., Morin, J. D. & Hellmann, J. Corneal diameter, axial length, and intraocular pressure in premature infants. Ophthalmology 99, 1296\u20131300 (1992).","journal-title":"Ophthalmology"},{"issue":"Pt 6","key":"8680_CR16","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/eye.1994.163","volume":"8","author":"C O\u2019Brien","year":"1994","unstructured":"O\u2019Brien, C. & Clark, D. Ocular biometry in pre-term infants without retinopathy of prematurity. Eye (Lond). 8(Pt 6), 662\u2013665 (1994).","journal-title":"Eye (Lond)."},{"key":"8680_CR17","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/S0161-6420(95)30950-5","volume":"102","author":"SJ Isenberg","year":"1995","unstructured":"Isenberg, S. J. et al. Growth of the internal and external eye in term and preterm infants. Ophthalmology 102, 827\u2013830 (1995).","journal-title":"Ophthalmology"},{"key":"8680_CR18","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1136\/bjo.80.10.918","volume":"80","author":"HC Fledelius","year":"1996","unstructured":"Fledelius, H. C. & Christensen, A. C. Reappraisal of the human ocular growth curve in fetal life, infancy, and early childhood. Br. J. Ophthalmol. 80, 918\u2013921 (1996).","journal-title":"Br. J. Ophthalmol."},{"key":"8680_CR19","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1167\/iovs.02-0124","volume":"44","author":"A Cook","year":"2003","unstructured":"Cook, A., White, S., Batterbury, M. & Clark, D. Ocular growth and refractive error development in premature infants without retinopathy of prematurity. Invest. Ophthalmol. Vis. Sci. 44, 953\u2013960 (2003).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"8680_CR20","doi-asserted-by":"publisher","first-page":"146","DOI":"10.5935\/0004-2749.20150038","volume":"78","author":"O Ozdemir","year":"2015","unstructured":"Ozdemir, O. et al. The relationship of birth weight, gestational age, and postmenstrual age with ocular biometry parameters in premature infants. Arq. Bras. Oftalmol. 78, 146\u2013149 (2015).","journal-title":"Arq. Bras. Oftalmol."},{"key":"8680_CR21","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1167\/iovs.18-24776","volume":"60","author":"D Kardaras","year":"2019","unstructured":"Kardaras, D. et al. The association between retinopathy of prematurity and ocular growth. Invest. Ophthalmol. Vis. Sci. 60, 98\u2013106 (2019).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"8680_CR22","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1001\/archopht.1986.01050190084044","volume":"104","author":"Y Inagaki","year":"1986","unstructured":"Inagaki, Y. The rapid change of corneal curvature in the neonatal period and infancy. Arch. Ophthalmol. 104, 1026\u20131027 (1986).","journal-title":"Arch. Ophthalmol."},{"key":"8680_CR23","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/S0161-6420(01)01017-X","volume":"109","author":"EYJ Ng","year":"2002","unstructured":"Ng, E. Y. J. et al. A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 1. Visual function and structural outcome. Ophthalmology 109, 928\u2013935 (2002).","journal-title":"Ophthalmology"},{"key":"8680_CR24","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/S0161-6420(99)00042-1","volume":"107","author":"MJ Banach","year":"2000","unstructured":"Banach, M. J., Ferrone, P. J. & Trese, M. T. A comparison of dense versus less dense diode laser photocoagulation patterns for threshold retinopathy of prematurity. Ophthalmology 107, 324\u2013327 (2000) (discussion 328).","journal-title":"Ophthalmology"},{"key":"8680_CR25","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/00006982-200302000-00033","volume":"23","author":"S Shaikh","year":"2003","unstructured":"Shaikh, S. et al. Inadvertent skip areas in treatment of zone 1 retinopathy of prematurity. Retina 23, 128\u2013131 (2003).","journal-title":"Retina"},{"key":"8680_CR26","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/aos.14406","volume":"98","author":"U Spandau","year":"2020","unstructured":"Spandau, U., Larsson, E. & Holmstr\u00f6m, G. Inadequate laser coagulation is an important cause of treatment failure in Type 1 retinopathy of prematurity. Acta Ophthalmol. 98, 795\u2013799 (2020).","journal-title":"Acta Ophthalmol."},{"key":"8680_CR27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ajo.2018.09.039","volume":"198","author":"TA Chen","year":"2019","unstructured":"Chen, T. A. et al. A spectrum of regression following intravitreal bevacizumab in retinopathy of prematurity. Am. J. Ophthalmol. 198, 63\u201369 (2019).","journal-title":"Am. J. Ophthalmol."},{"key":"8680_CR28","first-page":"3169","volume":"35","author":"X Reynaud","year":"1994","unstructured":"Reynaud, X. & Dorey, C. K. Extraretinal neovascularization induced by hypoxic episodes in the neonatal rat. Invest. Ophthalmol. Vis. Sci. 35, 3169\u20133177 (1994).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"8680_CR29","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1001\/archopht.1996.01100140410008","volume":"114","author":"CK Dorey","year":"1996","unstructured":"Dorey, C. K., Aouididi, S., Reynaud, X., Dvorak, H. F. & Brown, L. F. Correlation of vascular permeability factor\/vascular endothelial growth factor with extraretinal neovascularization in the rat. Arch. Ophthalmol. 114, 1210\u20131217 (1996).","journal-title":"Arch. Ophthalmol."},{"key":"8680_CR30","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ajo.2009.04.018","volume":"148","author":"EM Lad","year":"2009","unstructured":"Lad, E. M., Hernandez-Boussard, T., Morton, J. M. & Moshfeghi, D. M. Incidence of retinopathy of prematurity in the United States: 1997 through 2005. Am. J. Ophthalmol. 148, 451\u2013458 (2009).","journal-title":"Am. J. Ophthalmol."},{"key":"8680_CR31","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1136\/bjophthalmol-2018-313156","volume":"103","author":"TK Redd","year":"2018","unstructured":"Redd, T. K. et al. Evaluation of a deep learning image assessment system for detecting severe retinopathy of prematurity. Br. J. Ophthalmol. 103, 580\u2013584 (2018).","journal-title":"Br. J. Ophthalmol."},{"key":"8680_CR32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1167\/tvst.9.2.5","volume":"9","author":"BA Scruggs","year":"2020","unstructured":"Scruggs, B. A., Chan, R. V. P., Kalpathy-Cramer, J., Chiang, M. F. & Campbell, J. P. Artificial intelligence in retinopathy of prematurity diagnosis. Transl. Vis. Sci. Technol. 9, 5 (2020).","journal-title":"Transl. Vis. Sci. Technol."},{"key":"8680_CR33","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1475-1313.1991.tb00207.x","volume":"11","author":"MP Snead","year":"1991","unstructured":"Snead, M. P., Hardman Lea, S., Rubinstein, M. P., Reynolds, K. & Haworth, S. M. Determination of the nodal point position in the pseudophakic eye. Ophthalmic Physiol. Opt. 11, 105\u2013108 (1991).","journal-title":"Ophthalmic Physiol. Opt."},{"key":"8680_CR34","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/S0886-3350(13)80338-0","volume":"19","author":"KJ Hoffer","year":"1993","unstructured":"Hoffer, K. J. The Hoffer Q formula: a comparison of theoretic and regression formulas. J. Cataract Refract. Surg. 19, 700\u2013712 (1993).","journal-title":"J. Cataract Refract. Surg."},{"key":"8680_CR35","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jcjo.2014.11.005","volume":"50","author":"SK Wang","year":"2015","unstructured":"Wang, S. K. et al. SUNDROP: six years of screening for retinopathy of prematurity with telemedicine. Can. J. Ophthalmol. 50, 101\u2013106 (2015).","journal-title":"Can. J. Ophthalmol."},{"key":"8680_CR36","doi-asserted-by":"publisher","first-page":"e0116669","DOI":"10.1371\/journal.pone.0116669","volume":"10","author":"Y Chen","year":"2015","unstructured":"Chen, Y. et al. Time at treatment of severe retinopathy of prematurity in China: recommendations for guidelines in more mature infants. PLoS ONE 10, e0116669 (2015).","journal-title":"PLoS ONE"},{"key":"8680_CR37","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","volume":"121","author":"Early Treatment For Retinopathy Of Prematurity Cooperative Group","year":"2003","unstructured":"Early Treatment For Retinopathy Of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch. Ophthalmol. 121, 1684\u20131694 (2003).","journal-title":"Arch. Ophthalmol."},{"key":"8680_CR38","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1097\/IAE.0b013e318177f934","volume":"28","author":"HA Mintz-Hittner","year":"2008","unstructured":"Mintz-Hittner, H. A. & Kuffel, R. R. Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II. Retina 28, 831\u2013838 (2008).","journal-title":"Retina"},{"key":"8680_CR39","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ajo.2008.05.010","volume":"146","author":"Y Soh","year":"2008","unstructured":"Soh, Y., Fujino, T. & Hatsukawa, Y. Progression and timing of treatment of zone I retinopathy of prematurity. Am. J. Ophthalmol. 146, 369\u2013374 (2008).","journal-title":"Am. J. Ophthalmol."},{"key":"8680_CR40","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1001\/archophthalmol.2010.34","volume":"128","author":"SP Christiansen","year":"2010","unstructured":"Christiansen, S. P. et al. Progression of type 2 to type 1 retinopathy of prematurity in the Early Treatment for Retinopathy of Prematurity Study. Arch. Ophthalmol. 128, 461\u2013465 (2010).","journal-title":"Arch. Ophthalmol."},{"key":"8680_CR41","doi-asserted-by":"crossref","unstructured":"Mintz-Hittner, H. A., Kennedy, K. A., Chuang, A. Z. & BEAT-ROP Cooperative Group. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N. Engl. J. Med. 364, 603\u201315 (2011).","DOI":"10.1056\/NEJMoa1007374"},{"key":"8680_CR42","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1001\/jamaophthalmol.2014.2772","volume":"132","author":"MM Geloneck","year":"2014","unstructured":"Geloneck, M. M. et al. Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial. JAMA Ophthalmol. 132, 1327\u20131333 (2014).","journal-title":"JAMA Ophthalmol."},{"key":"8680_CR43","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jaapos.2013.12.003","volume":"18","author":"DH Shin","year":"2014","unstructured":"Shin, D. H. et al. Risk factors and rate of progression for zone I versus zone II type 1 retinopathy of prematurity. J. AAPOS 18, 124\u2013128 (2014).","journal-title":"J. AAPOS"},{"key":"8680_CR44","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ophtha.2014.07.050","volume":"122","author":"ME Hartnett","year":"2015","unstructured":"Hartnett, M. E. Pathophysiology and mechanisms of severe retinopathy of prematurity. Ophthalmology 122, 200\u2013210 (2015).","journal-title":"Ophthalmology"},{"key":"8680_CR45","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/00006982-199703000-00009","volume":"17","author":"RJ Hairston","year":"1997","unstructured":"Hairston, R. J., Maguire, A. M., Vitale, S. & Green, W. R. Morphometric analysis of pars plana development in humans. Retina 17, 135\u2013138 (1997).","journal-title":"Retina"},{"key":"8680_CR46","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1001\/archopht.1992.01080180074031","volume":"110","author":"AL Aiello","year":"1992","unstructured":"Aiello, A. L., Tran, V. T. & Rao, N. A. Postnatal development of the ciliary body and pars plana. A morphometric study in childhood. Arch. Ophthalmol. 110, 802\u2013805 (1992).","journal-title":"Arch. Ophthalmol."},{"key":"8680_CR47","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ajo.2015.09.023","volume":"161","author":"A Hendrickson","year":"2016","unstructured":"Hendrickson, A. Development of retinal layers in prenatal human retina. Am. J. Ophthalmol. 161, 29-35.e1 (2016).","journal-title":"Am. J. Ophthalmol."},{"key":"8680_CR48","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1016\/S0161-6420(98)91214-3","volume":"105","author":"AR Rudnicka","year":"1998","unstructured":"Rudnicka, A. R., Burk, R. O., Edgar, D. F. & Fitzke, F. W. Magnification characteristics of fundus imaging systems. Ophthalmology 105, 2186\u20132192 (1998).","journal-title":"Ophthalmology"},{"key":"8680_CR49","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3928\/23258160-20140122-01","volume":"45","author":"N Fijalkowski","year":"2014","unstructured":"Fijalkowski, N. et al. Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP): Five years of screening with telemedicine. Ophthalmic Surg. Lasers Imaging Retina 45, 106\u2013113 (2014).","journal-title":"Ophthalmic Surg. Lasers Imaging Retina"},{"key":"8680_CR50","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s00417-009-1077-7","volume":"247","author":"B Lorenz","year":"2009","unstructured":"Lorenz, B., Spasovska, K., Elflein, H. & Schneider, N. Wide-field digital imaging based telemedicine for screening for acute retinopathy of prematurity (ROP). Six-year results of a multicentre field study. Graefes Arch. Clin. Exp. Ophthalmol. 247, 1251\u20131262 (2009).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"8680_CR51","doi-asserted-by":"publisher","first-page":"e0138701","DOI":"10.1371\/journal.pone.0138701","volume":"10","author":"RA Jonas","year":"2015","unstructured":"Jonas, R. A. et al. Optic disc-fovea distance, axial length and Parapapillary Zones. The Beijing Eye Study 2011. PLoS ONE 10, e0138701 (2015).","journal-title":"PLoS ONE"},{"key":"8680_CR52","doi-asserted-by":"publisher","first-page":"4683","DOI":"10.1167\/iovs.06-0152","volume":"47","author":"DJ De Silva","year":"2006","unstructured":"De Silva, D. J. et al. Optic disk size and optic disk-to-fovea distance in preterm and full-term infants. Invest. Ophthalmol. Vis. Sci. 47, 4683\u20134686 (2006).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"8680_CR53","doi-asserted-by":"publisher","first-page":"4791","DOI":"10.1167\/iovs.12-10713","volume":"54","author":"LS Lim","year":"2013","unstructured":"Lim, L. S. et al. Distribution and determinants of eye size and shape in newborn children: a magnetic resonance imaging analysis. Invest. Ophthalmol. Vis. Sci. 54, 4791\u20134797 (2013).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"8680_CR54","doi-asserted-by":"publisher","first-page":"8878","DOI":"10.1167\/iovs.11-7269","volume":"52","author":"LS Lim","year":"2011","unstructured":"Lim, L. S. et al. Variations in eye volume, surface area, and shape with refractive error in young children by magnetic resonance imaging analysis. Invest. Ophthalmol. Vis. Sci. 52, 8878\u20138883 (2011).","journal-title":"Invest. Ophthalmol. Vis. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08680-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08680-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08680-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:38:49Z","timestamp":1669336729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08680-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,18]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["8680"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-08680-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,18]]},"assertion":[{"value":"25 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.K.W., None; E.K., Genentech (C), RetiHealth Inc (C,E);, M.Z., None; M.H.J., None; A.A., None; N.F.C, Genentech (E); J.K., Pr3vent INC (F,CEO); D.M.M, 1-800Contacts (BOD,E), Akceso Advisors AG (C), Akebia (SAB), Alcon (C), Aldeyra Therapeutics (PI), Alexion (C), Allegro (SAB), Apellis (PI), Bayer Pharma AG (SC,C), CMEOutfitters.com (C), Congruence Medical Solutions (C), dSentz, Inc. (F,E,BOD), Grand Legend Technology, LTD (E), Iconic Therapeutics (SC), Irenix (SAB), Linc (F,E,BOD), M3 Global Research (C), Northwell Health (C), Novartis Pharmaceuticals (DMC, C), Ocular Surgery News (C), Pr3vent INC (F,E,BOD), Praxis UNS, Inc. (C), Prime Medical Education (C), Promisight, Inc (F,E,BOD), Pykus (E,SAB), Regeneron (SC,PI), Retina Technologies LLC (SAB,C,E), Retina Today\/Pentavision (C), Shapiro Law Group (C), SLACK, Inc (C), Versl, Inc. (F,E), Vindico (C), Visunex (E,SAB).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4717"}}